#biotech — FinScans

📈 Stocks

Parabilis Eyes $475 Million IPO on US Exchange to Fund Cancer Drug Trials

June 4, 2026 (68 days ago)

Cancer drugmaker Parabilis aims to raise $475 million in a US IPO, testing biotech investor sentiment as the company progresses its oncology…

XBI SPX

🌍 US Read More →

📈 Stocks

Ebola Cure Search: Scientists Trace Survivors' Blood in Remote Mountains

June 2, 2026 (71 days ago)

Scientists are tracking Ebola survivors in remote mountains to harvest antibodies for a cure, offering new hope against the virus and potential…

GILD IBB

Kardigan Files IPO to Fund Cardiovascular Disease Therapies

May 26, 2026 (77 days ago)

Kardigan IPO filing marks a milestone in cardiovascular drug development, highlighting renewed investor interest in biotech innovations beyond oncology.

KARD

🌍 US Read More →

📊 ETF IBB 📉 Bearish

Trump’s FDA Commissioner Is Resigning With Agency in Turmoil

May 12, 2026 (91 days ago)

FDA Commissioner Marty Makary’s resignation throws the agency into turmoil, threatening drug approvals and pressuring biotech and healthcare stocks.

▼ FDA Commissioner Makary resigns

📅 Short 🌍 US Read More →

📈 Stocks XLV 📉 Bearish

Clashes, Turmoil and Paranoia: Inside Trump’s FDA

May 8, 2026 (95 days ago)

FDA gridlock clouds drug approval timelines, pressuring healthcare stocks and ETFs like XLV and IBB.

▼ Escalating reports of FDA dysfunction deepen sector uncertainty.

📅 Short 🌍 US Read More →